Ryvu Therapeutics SA Cash Flow Reinvestment Rate
Ryvu Therapeutics SA cash flow reinvestment rate. Ryvu Therapeutics SA (RVU) has a Cash Flow Reinvestment Rate of 3.31x as of December 2022, reinvesting zł198.08 Million (capex zł4.22 Million plus investments zł-193.87 Million) from operating cash flow of zł59.92 Million. Explore RVU operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Ryvu Therapeutics SA (2017–2022)
Cash flow reinvestment rate of Ryvu Therapeutics SA from 2017 to 2022. Historical reinvestment intensity for Ryvu Therapeutics SA across 2 annual periods. Explore reinvestment intensity of Ryvu Therapeutics SA to see what proportion of operating cash flow is directed to capital expenditures.
Ryvu Therapeutics SA Cash Flow Reinvestment Rate by Year (2017–2022)
Ryvu Therapeutics SA cash flow reinvestment rate by year from 2017 to 2022. Year-by-year capital reinvestment analysis for Ryvu Therapeutics SA. For the full cash flow conversion analysis, see Ryvu Therapeutics SA cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.47x | zł9.98 Million | zł21.32 Million | zł9.29 Million | ▼ -85.8% |
| 2017 | 3.30x | zł36.26 Million | zł10.98 Million | zł21.56 Million | — |